- Office Hours
- Start Something
- Venture Creation Program
- Faculty Venture Creation Program
- Social Venture Creation Program
- Tech Bootcamp
- YEI Innovation Fund
- Technology Commercialization Program
- Venture Creation Consultants
- VC Advisors
- Mentor Program
- Undergraduate Portal
- Fellow selection and mentoring
- Early stage investment
- Access to industry networks
Robert Bettigole, Managing Partner, Elm Street Ventures
Rob Bettigole is a Yale alum and the founder and Managing Partner of Elm Street Ventures. Bettigole has broad experience as an entrepreneur and as a venture capitalist. His venture capital experience was gained as a partner at Rothschild Inc. and Investor AB, where his investments included Maxim Integrated Products, Gensia Pharmaceuticals, and Microgenics Corporation. Subsequently, he helped found Surety Technologies, Inc., a spin out from Bellcore, and Alexion (NASDAQ: ALXN), with researchers from the Yale Medical School. Before founding Elm Street, Bettigole was president of a family business, which he successfully developed and sold. He is a Licensed Professional Engineer and holds several U.S. and foreign patents.
Elon S. Boms, Founder and Managing Director, Launch Capital LLC
Elon Boms venture capital experience includes structuring bio-tech, consumer products and software development deals; he also has significant finance, consulting and marketing experience. Most recently, Boms was a managing consultant at Fidelity Investments where he worked primarily on strategy initiatives for financial investments in emerging markets. Prior to his work with Fidelity, Boms worked in Corporate Finance for Citigroup. He began his career as a brand manager at Georgia Pacific Company’s Dixie Foodservice division, where he assumed responsibility for $25M in capital investments and engineered a complete profit turnaround for the paper cup business.
Victor R. Budnick, Managing Director, Ironwood Capital
Victor has more than 25 years of experience in high technology venture capital investment, internal corporate venturing and mergers and acquisitions. He was YEI's inaugural Lead Venture Mentor (2010-2011) and currently serves as a managing director at Ironwood Capital in Avon, CT and is a partner and member of the investment committee of the Ironwood Equity Fund. For more than ten years, he was the President and Executive Director of Connecticut Innovations, the State of Connecticut's investor in emerging technology companies and a national model for public investment in the health care and technology sectors, achieving returns commensurate with the most successful private sector peers. He has built and maintained deep and long-standing relationships in the technology and venture communities. Victor received his undergraduate degree from Yale University and is a graduate of both Harvard Law School and the Yale School of Management.
Pamela M. Bunes, Chief Executive Officer, President, and Director of EpiEP, Inc.
Pamela served as Chief Executive Officer and President of Signalife Inc. (formerly Recom Managed Systems Inc.) before becoming CEO of EpiEP. Prior to that, she was Co- Chief Executive Officer of Signalife Inc. She served as Consultant of Signalife Inc and as Executive Account Manager of Ethicon Endo-Surgery, Inc. until her transfer to Biosense Webster. Biosense Webster and Ethicon Endo-Surgery are each subsidiaries of Johnson & Johnson (NYSE:JNJ). Pamela also served as Corporate Loan Officer and Vice President and Analyst for the Specialized Industries Mergers and Acquisitions Group of First Union National Bank. She had a 15-year career with Johnson & Johnson including senior positions in various business units of the Dow Component Company. Pamela has a Bachelors of Arts degree with double majors in Economics and Business Administration (Finance) from Converse College in Spartanburg, South Carolina.
Susan Froshauer, Ph.D., Chief Scientific Officer, Rib-X Pharmaceuticals, Inc.
Susan Froshauer previous served as Rib-X's CEO. Under her leadership, the company has raised more than $148 million in private equity and grown a pipeline of one Phase 3 (delafloxacin) and one Phase 2 (radezolid) clinical stage programs and an antibiotic drug discovery process to sustain the continual pipeline build. Dr. Froshauer is the recipient of the Pfizer Central Research Award and the Connecticut Technology Council's Women of Innovation 2006 Award for Entrepreneurial Innovation and Leadership. She was honored in 2008 by the DNA EpiCenter in New London, CT as a Barbara McClintock Scholar and by the Connecticut Women's Hall of Fame as a member of the New Century of Women in Science. Dr. Froshauer serves on the board of CURE and on the University of Connecticut R & D Board. She has also served on Connecticut's Technology Transfer and Commercialization Advisory Board of the Governor's Competitiveness Council.
Michael Inwald, President and Founder, Cheeseboy
Michael Inwald is the Founder and President of Cheeseboy, America’s first quick-service grilled cheese franchise concept. The company was launched during Michael’s tenure as an MBA candidate at the Yale School of Management in 2009. After receiving funding for his venture, Michael opened the first location in Milford, CT and has since grown Cheeseboy into a regional quick-service chain across the Northeast. Prior to starting graduate school, Michael was an Account Supervisor at Ogilvy & Mather and managed new business development for Ogilvy’s healthcare division. Before joining Ogilvy, Michael managed multiple interactive accounts at CoActive Marketing and served as Director of Marketing for Steve & Barry’s, a national apparel retail chain with over 130 stores across the country at the time. Previously, Michael owned and operated Business World Review, a media company that specialized in video/multimedia production, business news distribution, and web video streaming. Michael graduated from Cornell University in 2003, receiving his B.A. in Liberal Arts with concentrations in Biology and Film Production. He is an avid traveler, recreational musician, and a proud volunteer and supporter of Paul Newman’s SeriousFun Children’s Network, an organization that provides life-changing camp experiences for children with severe medical conditions.
Andrew Greenawalt, President, Gnostic Ventures
Andy Greenawalt is a serial entrepreneur in the Software as a Service (SaaS) market, frequent speaker and technology advocate. Greenawalt currently serves as the President of Gnostic Ventures, providing venture consulting, due diligence services and an incubation platform for SaaS businesses. He is also the CEO of Continuity Engine as well as serving as the entrepreneur partner with the CTech accelerator in New Haven. Prior to Continuity Engine, Greenawalt founded & CTO of Perimeter eSecurity, an Inc. 500 information security company, that services more than 2,500 banks and credit unions.
Miles Lasater, COO, Higher One
Miles Lasater is a Yale alum and co-founder of HigherOne. He has been a member of the invention team at Walker Digital, where he worked on intellectual property for companies such as Priceline and Retail DNA, and has worked in Silicon Valley as a computer consultant. During college, he was Rookie of the Year at Flying Colors Painting where he managed a residential painting franchise. Active in the New Haven community, Lasater is a member of the Port Authority of New Haven and Yale's Advisory Committee on Investor Responsibility. He founded the Yale Entrepreneurial Society, where he also serves on the board of directors. He is also the creator of Cluefest, an annual city-wide scavenger hunt.
David A. Lewin, Ph.D., Sr. Associate Director of Licensing, Office of Cooperative Research, Yale University
David Lewin, Ph.D., is Sr. Associate Director of Licensing for Yale University's Office of Cooperative Research ("OCR"), which is the technology transfer office for Yale. His responsibilities in this role encompass primarily life science technology evaluation, intellectual property management, technology marketing, licensing strategy and negotiation, and management of relationships with commercial partners; he joined OCR in 2005. Recently, he was a recipient, along with his colleagues at Oncolys Biopharma, a Japanese biotechnology company, and Bristol-Meyers Squibb, of the Licensing Executives Society 2011 Deals of Distinction Award for their efforts to commercialize a Yale-invented HIV/AIDS treatment, festinavir. Prior to coming to OCR, Lewin was a group leader at a Connecticut biotechnology company, CuraGen Corporation, where he was responsible for managing hte business and scientific relationships between CuraGen and its genomics/proteomics discovery partners Genentech, Roche, Alexion, Mitsubishi, and others. He subsequently led a biomarket discovery and development project group that implemented clinical biomarkers for CuraGen's protein therapeutic velafirmin, a candidate treatment for oral mucusitis. Lewin joined CuraGen in 1997 after receiving his Ph.D. from the Department of Cell Biology at Yale University; he holds a B.A. in biochemistry and cell biology from the University of California, San Diego.
Harley Lippman - Founder and CEO, Genesis10 & CEO, Infinity Info Systems
Harley Lippman is the Founder and CEO of Genesis10 and the CEO of Infinity Info Systems—two companies dedicated to delivering innovative and proven business and technology solutions and talent management to clients throughout North America. Genesis10 is a $185 million privately-held business and technology consulting and talent management solutions firm founded in 1999 to help companies drive business and technology initiatives. Genesis10 became the major stockholder of prominent customer relationship management (CRM) solutions experts, Infinity Info Systems, in January of 2014. Prior to starting Genesis10, Harley was the founder and sole owner of Triad Data Inc., an information technology consulting firm. Harley serves on the boards of many business, educational and cultural organizations. He is an Executive Committee member on the American Israel Public Affairs Committee. He serves by Presidential appointment and Senate confirmation as a member of the Commission of the Preservation of America’s Heritage Abroad. He is a member of the board of trustees of NYU Langone Medical Center. Harley is a member of the Yale School of Management Board of Advisors and a member of the Dean’s Advisory Board at Columbia University’s Graduate School of International and Public Affairs.
Jennifer Staple-Clark - Founder and CEO, Unite for Sight
In 2000, Jennifer Staple-Clark, then a sophomore at Yale University, founded Unite For Sight in her dorm room. Due to Jennifer's leadership and her focus on entrepreneurial innovation, Unite For Sight is a leader in providing cost-effective care to the world's poorest people. By investing human and financial resources in the social ventures of eye clinics in developing countries, Unite For Sight has provided eye care to more than 1.7 million people living in extreme poverty, including more than 65,000 sight-restoring surgeries. Additionally, Unite For Sight's Global Health University and Global Impact Corps programs develop and nurture the next generation of global health leaders. Unite For Sight also coordinates an annual Global Health & Innovation Conference, which convenes 2,200 participants and is the world's largest global health and social entrepreneurship conference.
Jennifer is the recipient of the 2011 John F. Kennedy New Frontier Award. In 2013, she received the Praxis Award in Professional Ethics from Villanova University. Jennifer also received the American Institute of Public Service's 2009 National Jefferson Award For Public Service, which is regarded as the "Nobel Prize" for public service. Additionally, Jennifer is a member of the Yale University President's Council on International Activities.
Leonora Valvo - Founder and CEO, etouches
Leonora Valvo is the founder and CEO of etouches, a web-based software-as-a-service enterprise solution that addresses all aspects of the event lifecycle. A lifelong entrepreneur, Leonora has launched four successful companies. etouches started out 12 years ago as a self-funded, independent meeting planning company, but has since transitioned into a full-fledged software company offering a suite of integrated event management and marketing tools designed to implement and support every phase of the event lifecycle. It closed a round of venture funding last year led by Greycroft Partners II that included investors such as Connecticut Innovations and Cava Capital.
Jarrod Yuster - CEO, Pico Quantitative Trading
Jarrod Yuster is the Co-Founder and Chief Executive Officer of PQT, an agency broker dealer that specializes in providing multi-asset electronic trading services. Prior to starting PQT, Mr. Yuster was a Managing Director and Global Head of Merrill Lynch's Portfolio and Electronic Trading, where he oversaw the business from inception in 2002 through February, 2009. Mr. Yuster has extensive experience starting trading businesses and building trading technology products. Prior to joining Merrill Lynch, Mr. Yuster led the quantitative and automated trading efforts in the portfolio trading group at Schwab Capital Markets where he joined from a Schwab-led start-up investment bank, Epoch Partners, which was sold to Goldman Sachs in 2001. Mr. Yuster has held positions in quantitative research and program trading at Bank of America Securities and Deutsche Bank Securities, both start-up trading desks. Jarrod Yuster received his M.S. in electrical engineering from Columbia University and a B.S. in electrical engineering from Yale University. Prior to working on Wall Street, Mr. Yuster worked as a product engineer, performing semiconductor research at Intel Corporation.